Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
2,811
Price
$69.29
Total Value
$194.77K
Shares Held After
111,314
% of Holdings
2.5%
Gemini Therapeutics, Inc. (GMTX)
Franchi Jean M. — Chief Financial Officer
Shares
4,075
Price
$62.86
Total Value
$256.15K
Shares Held After
78,424
% of Holdings
4.9%
Bio-Techne Corporation (TECH)
Herr Amy E. — Director
Shares
1,976
Price
$59.10
Total Value
$116.79K
Shares Held After
200
% of Holdings
90.8%
Neumora Therapeutics, Inc. Common Stock (NMRA)
Milligan Michael Lee — Title: Chief Financial Officer & Principal Accounting Officer
Shares
1,436
Price
$3.56
Total Value
$5.12K
Shares Held After
21,034
% of Holdings
6.4%
Neumora Therapeutics, Inc. Common Stock (NMRA)
BERNS PAUL L — Director
Shares
9,819
Price
$3.51
Total Value
$34.46K
Shares Held After
7,395,185
% of Holdings
0.1%
Neumora Therapeutics, Inc. Common Stock (NMRA)
Pinto Joshua — President
Shares
5,967
Price
$3.54
Total Value
$21.09K
Shares Held After
57,783
% of Holdings
9.4%
Neumora Therapeutics, Inc. Common Stock (NMRA)
Aurora Daljit Singh — Title: Chief Operating and Development Officer
Shares
6,165
Price
$3.56
Total Value
$21.92K
Shares Held After
82,770
% of Holdings
6.9%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
609
Price
$489.46
Total Value
$298.08K
Shares Held After
49,018
% of Holdings
1.2%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
7,989
Price
$46.53
Total Value
$371.71K
Shares Held After
106,929
% of Holdings
7.0%
Scholar Rock Holding Corp (SRRK)
Ho Junlin — GENERAL COUNSEL
Shares
9,580
Price
$46.53
Total Value
$445.74K
Shares Held After
241,545
% of Holdings
3.8%
Scholar Rock Holding Corp (SRRK)
Parlavecchio Caryn — CHRO
Shares
9,035
Price
$46.53
Total Value
$420.38K
Shares Held After
169,087
% of Holdings
5.1%
Scholar Rock Holding Corp (SRRK)
Marantz Jing L. — CHIEF MEDICAL OFFICER
Shares
4,157
Price
$46.53
Total Value
$193.42K
Shares Held After
126,012
% of Holdings
3.2%
Karyopharm Therapeutics Inc. (KPTI)
Poulton Stuart — EVP, Chief Development Officer
Shares
378
Price
$8.63
Total Value
$3.26K
Shares Held After
99,429
% of Holdings
0.4%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Ambrose Kristen — SVP & Chief Accounting Officer
Shares
1,557
Price
$489.46
Total Value
$762.09K
Shares Held After
8,388
% of Holdings
15.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Shares
2,031
Price
$489.46
Total Value
$994.09K
Shares Held After
21,544
% of Holdings
8.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
2,476
Price
$489.46
Total Value
$1.21M
Shares Held After
16,992
% of Holdings
12.7%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
4,321
Price
$28.26
Total Value
$122.12K
Shares Held After
105,211
% of Holdings
3.9%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
5,679
Price
$27.50
Total Value
$156.20K
Shares Held After
109,532
% of Holdings
4.9%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bunnage Mark E. — EVP, Chief Scientific Officer
Shares
2,437
Price
$489.46
Total Value
$1.19M
Shares Held After
9,668
% of Holdings
20.1%
Adagio Therapeutics, Inc. (ADGI)
Andersen Jill — Chief Legal Officer, Secretary
Shares
32,771
Price
$1.54
Total Value
$50.45K
Shares Held After
216,675
% of Holdings
13.1%
Adagio Therapeutics, Inc. (ADGI)
Lee Timothy Edward — Chief Commercial Officer
Shares
19,663
Price
$1.54
Total Value
$30.27K
Shares Held After
138,681
% of Holdings
12.4%
Adagio Therapeutics, Inc. (ADGI)
Duke William E. — Chief Financial Officer
Shares
19,663
Price
$1.54
Total Value
$30.27K
Shares Held After
128,681
% of Holdings
13.3%
EXELIXIS, INC. (EXEL)
Haley Patrick J. — EVP, Commercial
Shares
64,778
Price
$43.50
Total Value
$2.82M
Shares Held After
381,908
% of Holdings
14.5%
EXELIXIS, INC. (EXEL)
Haley Patrick J. — EVP, Commercial
Shares
3,036
Price
$43.84
Total Value
$133.10K
Shares Held After
446,686
% of Holdings
0.7%
EXELIXIS, INC. (EXEL)
Senner Christopher J. — EVP and CFO
Shares
30,617
Price
$43.67
Total Value
$1.34M
Shares Held After
976,092
% of Holdings
3.0%
Adagio Therapeutics, Inc. (ADGI)
Green Julie — Chief Human Resources Officer
Shares
19,663
Price
$1.54
Total Value
$30.27K
Shares Held After
128,681
% of Holdings
13.3%
Adagio Therapeutics, Inc. (ADGI)
Allen Robert D. III — Chief Scientific Officer
Shares
18,189
Price
$1.54
Total Value
$28.00K
Shares Held After
133,879
% of Holdings
12.0%
BridgeBio Pharma, Inc. (BBIO)
Trimarchi Thomas — President and CFO
Shares
200
Price
$75.38
Total Value
$15.08K
Shares Held After
336,585
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Trimarchi Thomas — President and CFO
Shares
13,400
Price
$74.71
Total Value
$1.00M
Shares Held After
336,785
% of Holdings
3.8%
BridgeBio Pharma, Inc. (BBIO)
Apuli Maricel — Chief Accounting Officer
Shares
510
Price
$74.31
Total Value
$37.90K
Shares Held After
123,945
% of Holdings
0.4%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
4,083
Price
$39.80
Total Value
$162.50K
Shares Held After
288,976
% of Holdings
1.4%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
8,159
Price
$39.22
Total Value
$319.96K
Shares Held After
293,059
% of Holdings
2.7%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
2,341
Price
$38.07
Total Value
$89.11K
Shares Held After
301,218
% of Holdings
0.8%
Protagonist Therapeutics, Inc. (PTGX)
Williams Lewis T — Director
Shares
18,000
Price
$82.42
Total Value
$1.48M
Shares Held After
7,825
% of Holdings
69.7%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
3,307
Price
$75.93
Total Value
$251.09K
Shares Held After
11,589
% of Holdings
22.2%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
4,793
Price
$75.57
Total Value
$362.22K
Shares Held After
14,896
% of Holdings
24.3%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
1,900
Price
$74.34
Total Value
$141.25K
Shares Held After
19,689
% of Holdings
8.8%
Day One Biopharmaceuticals, Inc. (DAWN)
VASCONCELLES MICHAEL — Head of Research and Dev.
Shares
2,728
Price
$11.60
Total Value
$31.65K
Shares Held After
4,397
% of Holdings
38.3%
Day One Biopharmaceuticals, Inc. (DAWN)
Bender Jeremy — Director
Shares
15,459
Price
$11.60
Total Value
$179.34K
Shares Held After
204,603
% of Holdings
7.0%
Day One Biopharmaceuticals, Inc. (DAWN)
York Charles N II — COO and CFO
Shares
6,065
Price
$11.60
Total Value
$70.36K
Shares Held After
312,025
% of Holdings
1.9%
Day One Biopharmaceuticals, Inc. (DAWN)
Dubow Adam — Gen Counsel & Secretary
Shares
6,395
Price
$11.60
Total Value
$74.19K
Shares Held After
72,694
% of Holdings
8.1%
Day One Biopharmaceuticals, Inc. (DAWN)
Merendino Lauren — Chief Commercial Officer
Shares
5,814
Price
$11.60
Total Value
$67.45K
Shares Held After
60,157
% of Holdings
8.8%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
4,150
Price
$70.01
Total Value
$290.55K
Shares Held After
53,541
% of Holdings
7.2%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
7,141
Price
$69.21
Total Value
$494.23K
Shares Held After
57,691
% of Holdings
11.0%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
76,857
Price
$1.31
Total Value
$100.54K
Shares Held After
1,520,498
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
7,875
Price
$480.75
Total Value
$3.79M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
14,625
Price
$480.75
Total Value
$7.03M
Shares Held After
0
% of Holdings
100.0%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Hodgson Ian — Chief Operating Officer
Shares
847
Price
$7.38
Total Value
$6.25K
Shares Held After
51,080
% of Holdings
1.6%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
2,437
Price
$15.00
Total Value
$36.55K
Shares Held After
0
% of Holdings
100.0%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
6,000
Price
$16.08
Total Value
$96.48K
Shares Held After
2,284,379
% of Holdings
0.3%
Showing 401–450 of 936 transactions (page 9 of 19)